|
The document outlines ongoing studies related to Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) being conducted by Covance Laboratories and 3M, including a 104-week dietary chronic study in rats and various toxicity and pharmacokinetic studies, with interim data provided for these investigations.
|
2000 |
AR226-0179
|
8VmG6jaBy2oz8ymMp9KYe2Emk |
12 |
|
The document outlines ongoing studies related to Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) being conducted by Covance Laboratories and 3M, including a 104-week dietary chronic study in rats and a 26-week capsule toxicity study in cynomolgus monkeys, with interim data provided for both.
|
2000 |
AR226-0179
|
n9MBbQDvq1DOozBoZzQeEJZqX |
12 |